Diabetes & CVD: Time for a multifactorial approach

10' education - Aug. 27, 2018 - ESC 2018 - Munich, Germany - John E Deanfield, MD - London, United Kingdom - Online CME

In recent years, new insights into the CV risk associated with diabetes have resulted in a new management approach of T2DM. Prof. Deanfield explains the rationale of a multifactorial approach.

Video navigation menu

Diabetes is associated with substantial CV risk, which is already present before diagnosis 0:25
Management of diabetes and the associated CV risk requires a multifactorial approach 2:57
How should CV risk reduction in diabetes be approached? 4:46
Too intensive glucose-lowering therapy may cause harm 7:14
New strategies to lower blood glucose have turned out to be real game changers 8:25

Educational information

This lecture was part of a CME accredited symposium: "Outcomes of GLP-1 RA in Diabetes & CVD: What are the key opportunities for cardiology practice?", held during ESC 2018 in Munich, Germany.

Faculty

Prof John E Deanfield, MD - cardiologist, University College London, London, UK

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk.

View slides of prof. Deanfield

Online-CME

This is available as accredited online CME for members. Click the button below to enroll:

Enroll

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.